Login

Jon Pilcher, CEO, Neuren Pharmaceuticals Ltd 00:00:00

Share On Facebook Share On Twitter

Neuren Pharmaceuticals hails FDA approval for trofinetide

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
I speak with OpenText CEO Mark Barrenechea about the company's fiscal performance.
00:00:00
Battling Drug Resistance - Maha Farhat, MD, MSc Gilbert S. Omenn Associate Professor of Biomedical Informatics, HMS
00:10:00
Insight Partners has helped over so many companies turn their vision into reality|Thilo Semmelbauer,Managing Director,Insight Partners
00:10:00
Silvercorp Metals Interview with Lon Shaver on Assay TV
00:10:00
Serene Confidence: Embracing Slowdowns | Ryan Detrick - Chief Market Strategist of Harbor Wealth Management
00:10:00
Incrementum AG: Life Out of Balance - A Reflection on Global Markets and Societal Challenges
00:10:00
Attracting Long-Term Institutional Capital in Junior Mining: Key Strategies
00:00:00
Stressed about your child's screen time -Dr. Nusheen Ameenuddin, a Mayo Clinic pediatrician
00:10:00
We relentlessly pursue therapeutic options to reduce and treat infectious and inflammatory disease|Joe Todisco,Chief Executive Officer,CorMedix Inc
00:00:00
Coronary atherosclerosis - Dr. Ángel Herraiz-Adillo
00:10:00
Sky Harbor Resources Eyes Major Uranium Exploration Success in 2024
00:10:00
Starcore International Mines: Gold Production, Exploration, and Strategic Growth

© 2017 - Neuhu+